**Core Concept**
Glanzmann disease, also known as Glanzmann thrombasthenia, is a rare inherited bleeding disorder characterized by a deficiency or dysfunction of the platelet glycoprotein IIb/IIIa complex. This complex plays a crucial role in platelet aggregation and clot formation.

**Why the Correct Answer is Right**
The correct answer involves the platelet glycoprotein IIb/IIIa complex, which is essential for platelet aggregation by binding to fibrinogen and von Willebrand factor. The absence or dysfunction of this complex impairs platelet aggregation, leading to prolonged bleeding. Glanzmann disease is caused by mutations in the ITGA2B or ITGB3 genes, which encode the alpha IIb and beta 3 subunits of the glycoprotein IIb/IIIa complex, respectively.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because Glanzmann disease is not caused by a deficiency of von Willebrand factor, but rather by a deficiency of the platelet glycoprotein IIb/IIIa complex.

**Option B:** This option is incorrect because Glanzmann disease is not characterized by a deficiency of factor VIII, which is associated with hemophilia A.

**Option C:** This option is incorrect because Glanzmann disease is not caused by a deficiency of platelet factor 4, which is involved in the regulation of platelet activation.

**Clinical Pearl / High-Yield Fact**
Glanzmann disease is often diagnosed in childhood or adolescence, and patients may present with symptoms such as petechiae, ecchymoses, and mucocutaneous bleeding. Treatment typically involves the use of platelet transfusions or desmopressin to enhance platelet function.

**Correct Answer:** D.